- Home
- ZIM vs VKTX Comparison
ZIM vs VKTX Comparison
Compare ZIM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIM
- VKTX
- Stock Information
- Founded
- ZIM 1945
- VKTX 2012
- Country
- ZIM Israel
- VKTX United States
- Employees
- ZIM N/A
- VKTX N/A
- Industry
- ZIM Marine Transportation
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- ZIM Consumer Discretionary
- VKTX Health Care
- Exchange
- ZIM Nasdaq
- VKTX Nasdaq
- Market Cap
- ZIM 2.4B
- VKTX 2.8B
- IPO Year
- ZIM 2021
- VKTX 2015
- Fundamental
- Price
- ZIM $14.33
- VKTX $24.99
- Analyst Decision
- ZIM Sell
- VKTX Strong Buy
- Analyst Count
- ZIM 4
- VKTX 12
- Target Price
- ZIM $13.95
- VKTX $89.50
- AVG Volume (30 Days)
- ZIM 6.7M
- VKTX 4.6M
- Earning Date
- ZIM 05-20-2025
- VKTX 04-23-2025
- Dividend Yield
- ZIM 55.65%
- VKTX N/A
- EPS Growth
- ZIM N/A
- VKTX N/A
- EPS
- ZIM 17.82
- VKTX N/A
- Revenue
- ZIM $8,427,400,000.00
- VKTX N/A
- Revenue This Year
- ZIM N/A
- VKTX N/A
- Revenue Next Year
- ZIM N/A
- VKTX N/A
- P/E Ratio
- ZIM $0.80
- VKTX N/A
- Revenue Growth
- ZIM 63.25
- VKTX N/A
- 52 Week Low
- ZIM $11.04
- VKTX $18.92
- 52 Week High
- ZIM $30.15
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- ZIM 47.52
- VKTX 49.24
- Support Level
- ZIM $12.66
- VKTX $21.23
- Resistance Level
- ZIM $14.23
- VKTX $26.95
- Average True Range (ATR)
- ZIM 1.03
- VKTX 2.20
- MACD
- ZIM 0.28
- VKTX 0.54
- Stochastic Oscillator
- ZIM 88.68
- VKTX 74.30
About ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.